Affinage

CEP85

Centrosomal protein of 85 kDa · UniProt Q6P2H3

Length
762 aa
Mass
85.6 kDa
Annotated
2026-06-09
10 papers in source corpus 4 papers cited in narrative 5 extracted findings
Cross-family judge vs UniProt: Affinage preferred faithfulness: 5/5 claims corpus-supported (100%)

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

CEP85 is a centrosomal scaffold protein that governs both centriole biogenesis and centrosome separation through direct, mutually exclusive kinase-coupled interactions (PMID:26220856, PMID:29712910). In centriole assembly, CEP85 directly binds STIL through a conserved interface, and this interaction is essential for centriolar targeting of STIL, PLK4 activation, and faithful daughter centriole formation (PMID:29712910). In centrosome integrity control, CEP85 localizes to the proximal ends of centrioles, directly binds Nek2A, and inhibits its kinase activity, cooperating with PP1γ to antagonize Nek2A and suppress precocious centrosome separation during interphase (PMID:26220856). At G2/M this restraint is relieved: CEP85 forms a PLK1–CEP85–Nek2A ternary complex in which PLK1 phosphorylates CEP85 in a Nek2A-binding-dependent manner, driving CEP85 to dissociate from phospho-Nek2A and freeing active Nek2A to initiate centrosome disjunction (PMID:30611117). Beyond the centrosome, the CEP85–STIL complex is recruited by PLK4 to the leading edge of migrating cells, where it sustains ARP2 (ACTR2) phosphorylation and actin-dependent directional motility (PMID:32107292).

Mechanistic history

Synthesis pass · year-by-year structured walk · 5 steps
  1. 2015 High

    Established CEP85 as a centrosomal negative regulator of centrosome separation, answering how Nek2A activity is restrained during interphase.

    Evidence Co-IP, in vitro kinase assay, immunofluorescence, and siRNA/overexpression phenotyping with domain mapping in cells

    PMID:26220856

    Open questions at the time
    • Structural basis of the CEP85–Nek2A interface not defined
    • Mechanism by which PP1γ cooperates with CEP85 not resolved
    • How the inhibition is relieved at mitotic entry not addressed
  2. 2018 High

    Defined the direct CEP85–STIL interface and showed it is required for STIL centriolar targeting, PLK4 activation, and daughter centriole assembly, placing CEP85 in the centriole biogenesis pathway.

    Evidence BioID proximity mapping, structural determination, structure-guided mutagenesis with in vivo rescue, and Co-IP

    PMID:29712910

    Open questions at the time
    • Temporal coordination between the STIL-binding and Nek2A-binding roles of CEP85 not addressed
    • Whether the same CEP85 molecules participate in both functions unknown
  3. 2018 High

    Resolved how interphase inhibition of Nek2A is switched off, showing PLK1 phosphorylates CEP85 within a ternary complex to release active Nek2A and trigger disjunction at G2/M.

    Evidence Co-IP establishing ternary complex, in vitro kinase assays, phospho-specific analyses, and cell-based assays with mutant forms

    PMID:30611117

    Open questions at the time
    • Specific PLK1 phosphosites on CEP85 and their structural consequences not fully mapped
    • How phosphorylation selectively dissociates CEP85 from phospho-Nek2A but not unphosphorylated Nek2A unresolved
  4. 2020 High

    Extended CEP85 function beyond the centrosome by showing the CEP85–STIL complex drives directional migration through PLK4-dependent leading-edge recruitment and ARP2 phosphorylation.

    Evidence Structure-guided mutagenesis, leading-edge localization, siRNA knockdown, ARP2 phosphorylation assays, and directed migration assays

    PMID:32107292

    Open questions at the time
    • Direct link between CEP85–STIL and ARP2 kinase not established
    • Whether this role is separable from centriolar duplication function unclear
  5. 2025 Low

    Implicated CEP85 in macrophage phagocytosis, hinting at a function outside cell-division contexts.

    Evidence Overexpression in monocyte-derived macrophages with phagocytosis assay (preprint)

    Open questions at the time
    • Single overexpression assay in a preprint with no mechanistic pathway placement
    • No molecular partners or signaling readout identified
    • Not independently confirmed

Open questions

Synthesis pass · forward-looking unresolved questions
  • How CEP85 partitions its centriole-biogenesis (STIL/PLK4), centrosome-disjunction (Nek2A/PLK1/PP1γ), and migration roles across the cell cycle and cell types remains unresolved.
  • No structural model integrating the STIL- and Nek2A-binding regions
  • Spatiotemporal regulation distinguishing the functions not defined

Mechanism profile

Synthesis pass · controlled-vocabulary classification · explore literature graph →
Molecular activity
GO:0060090 molecular adaptor activity 2 GO:0098772 molecular function regulator activity 1
Localization
GO:0005815 microtubule organizing center 1
Pathway
R-HSA-1640170 Cell Cycle 3 R-HSA-1852241 Organelle biogenesis and maintenance 1
Complex memberships
CEP85–STIL complexPLK1–CEP85–Nek2A ternary complex

Evidence

Reading pass · 5 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
2018 CEP85 directly binds STIL through a conserved interaction interface involving a previously uncharacterised domain of STIL; this interaction is essential for efficient centriolar targeting of STIL, PLK4 activation, and faithful daughter centriole assembly. Protein proximity mapping (BioID), NMR/structural methods, structure-guided mutational analyses in vivo, Co-IP Nature Communications High 29712910
2015 CEP85 localizes to centrosomes, colocalizes with Nek2A at the proximal ends of centrioles forming a granule meshwork, directly binds Nek2A, and inhibits Nek2A kinase activity in vitro; depletion of CEP85 causes precocious centrosome separation while overexpression (with Eg5 inhibition) blocks centrosome disjunction. CEP85 cooperates with PP1γ to antagonize Nek2A activity during interphase. Co-immunoprecipitation, in vitro kinase assay, immunofluorescence/localization, siRNA depletion, overexpression with domain-mapping Journal of Cell Science High 26220856
2018 PLK1 interacts with CEP85 and forms a ternary complex with CEP85–Nek2A. Nek2A binding to CEP85 is required (but not Nek2A kinase activity) for CEP85 to be phosphorylated by PLK1. PLK1-mediated phosphorylation of CEP85 causes its dissociation specifically from phospho-Nek2A, freeing phospho-Nek2A to become active. Both PLK1 and Nek2A are required for endogenous CEP85 phosphorylation, and timely CEP85 phosphorylation at G2/M is essential for centrosome disjunction. Co-immunoprecipitation, in vitro kinase assay, phospho-specific analyses, cell-based functional assays with mutant forms iScience High 30611117
2020 The CEP85–STIL interaction is required for directional cancer cell migration. PLK4 drives recruitment of CEP85 and STIL to the leading edge of migrating cells to promote protrusive activity; disruption of the CEP85–STIL–PLK4 interaction reduces ARP2 (ACTR2) phosphorylation and impairs actin cytoskeleton reorganization, thereby impairing directional cell motility. Mutational analyses, fluorescence localization (leading-edge recruitment), siRNA knockdown, phosphorylation assays (ARP2), directed cell migration assays Journal of Cell Science High 32107292
2025 CEP85 overexpression in monocyte-derived macrophages disrupts phagocytosis, indicating a functional role in phagocytic activity. In vitro overexpression in monocyte-derived macrophages with phagocytosis assay bioRxivpreprint Low

Source papers

Stage 0 corpus · 10 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
2018 Direct binding of CEP85 to STIL ensures robust PLK4 activation and efficient centriole assembly. Nature communications 38 29712910
2015 Characterization of Cep85 - a new antagonist of Nek2A that is involved in the regulation of centrosome disjunction. Journal of cell science 17 26220856
2012 Identification of endometriosis-related genes by representational difference analysis of cDNA. The Australian & New Zealand journal of obstetrics & gynaecology 17 22276910
2020 Direct interaction between CEP85 and STIL mediates PLK4-driven directed cell migration. Journal of cell science 13 32107292
2023 circRNA-SMO upregulates CEP85 to promote proliferation and migration of glioblastoma via sponging miR-326. Histology and histopathology 10 36718820
2023 Transcriptome-wide association study of circulating IgE levels identifies novel targets for asthma and allergic diseases. Frontiers in immunology 8 36793728
2018 Cep85 Relays Plk1 Activity to Phosphorylated Nek2A for Its Timely Activation in Centrosome Disjunction. iScience 7 30611117
2025 Genetic insights into non-obstructive azoospermia: Implications for diagnosis and TESE outcomes. Journal of assisted reproduction and genetics 3 39932629
2024 Integrated miRNA and mRNA Sequencing Reveals the Sterility Mechanism in Hybrid Yellow Catfish Resulting from Pelteobagrus fulvidraco (♀) × Pelteobagrus vachelli (♂). Animals : an open access journal from MDPI 3 38891632
2010 Reduced expression of Sytl 1 and Ccdc21 and impaired induction of Mt I by oxidative stress in SII-K1 knockout mice. Drug discoveries & therapeutics 3 22491241

Missed literature

Know a paper Affinage missed for CEP85? Flag it for the maintainers and the community.

No submissions yet.